<DOC>
	<DOCNO>NCT03076476</DOCNO>
	<brief_summary>Angina heart attack cause narrowing coronary artery ( blood vessel ) supply heart . These narrowing open use balloon stent ( angioplasty ) . Traditionally , stent construct metal permanent . However , new stent construct carbohydrate polymer ( scaffold ) , allow reabsorb time leave permanent implant . New data suggest scaffold appear reduce recurrent angina may alter blood flow artery . However , know whether due scaffold way scaffold insert . In study hope measure blood flow heart ass change flow stent scaffold insertion . It also important know whether effect durable thus , cohort patient return 3-months restudied . These data important help u understand blood flow affect stent/scaffold selection device implantation technique whether result well long-term outcome .</brief_summary>
	<brief_title>Coronary Microcirculatory Bioresorbable Vascular Scaffolds</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>1 . Patient age &gt; 18 year , &lt; 75 year . 2 . Lesion suitability BVS deployment : target vessel calibre &gt; 2.3mm &lt; 3.8mm reference diameter , without significant tortuosity calcification . 3 . Listed singlevessel PCI procedure . 4 . Lesion length≤28mm ( accommodate single BVS/DES ) 5 . Preserved leave ventricular ejection fraction ( EF≥50 % ) . 1 . Patients confirm myocardial infarction within precede 2 month . 2 . Allergy intolerance aspirin , clopidogrel , prasugrel ticagrelor contraindication 12 month ' dual antiplatelet therapy . 3 . Contraindication use adenosine ( asthma/chronic lung disease document bronchoreactivity ) . 4 . Significant known comorbidity terminal condition life expectancy &lt; 6 month . 5 . Pregnancy . 6 . Coagulopathy warfarin treatment . 7 . Significant renal impairment ( baseline creatinine &gt; 130 mmol/l ) . 8 . Other comorbid condition may affect microcirculatory function troponin release ( eg . Seropositive inflammatory condition ) . 9 . Inability comply followup requirement . 10 . Target lesion left mainstem , saphenous vein arterial graft . 11 . Chronic total occlusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Coronary Stent</keyword>
	<keyword>PCI</keyword>
	<keyword>BVS</keyword>
	<keyword>Index microcirculatory resistance</keyword>
</DOC>